Literature DB >> 8703433

Recombinant outer-surface protein A (des-Cys1-OspA) from the Lyme disease spirochete Borrelia burgdorferi: high production levels in Saccharomyces cerevisiae yeast cultures.

O Mendoza-Vega, E Keppi, B Bouchon, M Nguyen, T Achstetter.   

Abstract

The recombinant outer-surface protein A with an N-terminally truncated form (des-Cys1-OspA) from the Lyme disease spirochete Borrelia burgdorferi was expressed in Saccharomyces cerevisiae at high production levels. Since the recombinant vaccine candidate expressed in Escherichia coli exhibits low production yields and the purification of lipoproteins appears to be difficult, we have investigated the secretion of a soluble recombinant OspA in the yeast S. cerevisiae. In this way, a Leu+ derivative of S. cerevisiae cI3ABYS86 was used as the host strain transformed with an expression plasmid containing the gene encoding des-Cys1-OspA and driven by the MF alpha 1 promoter. The fed-batch culture results revealed that an efficient secretion of des-Cys1-OspA is obtained with a high production level of about 2.1 g l-1 at a cell density of 101 g l-1 cell dry weight. The accumulation of recombinant protein in the supernatant exceeds 6% of the total yeast proteins when estimated by sodium dodecyl sulphate/polyacrylamide gel electrophoresis. Moreover, des-Cys1-OspA showed lower solubilities at high cell densities and, as a consequence, a fraction of the recombinant protein precipitated. An internal cleavage of the MF alpha 1 pro::des-Cys1-OspA precursor was also detected. However, in this case the cleavage occurred at a frequency such that the large amounts of the secreted des-Cys1-OspA could be employed for the evaluation of an immunogenic effect on animal immunization. These studies will extend the knowledge of the usefulness of OspA as a vaccine for Lyme borreliosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8703433     DOI: 10.1007/BF00172495

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  18 in total

1.  Protection of mice against the Lyme disease agent by immunizing with recombinant OspA.

Authors:  E Fikrig; S W Barthold; F S Kantor; R A Flavell
Journal:  Science       Date:  1990-10-26       Impact factor: 47.728

2.  Heterogeneity of major proteins in Lyme disease borreliae: a molecular analysis of North American and European isolates.

Authors:  A G Barbour; R A Heiland; T R Howe
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

Review 3.  Pathogenesis of Lyme disease.

Authors:  S E Malawista
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

Review 4.  Regulation of glucose metabolism in growing yeast cells.

Authors:  A Fiechter; G F Fuhrmann; O Käppeli
Journal:  Adv Microb Physiol       Date:  1981       Impact factor: 3.517

5.  Lipopeptides containing 2-(palmitoylamino)-6,7-bis(palmitoyloxy) heptanoic acid: synthesis, stereospecific stimulation of B-lymphocytes and macrophages, and adjuvanticity in vivo and in vitro.

Authors:  J Metzger; G Jung; W G Bessler; P Hoffmann; M Strecker; A Lieberknecht; U Schmidt
Journal:  J Med Chem       Date:  1991-07       Impact factor: 7.446

Review 6.  Perspective on the development of vaccines against Lyme disease.

Authors:  R Edelman
Journal:  Vaccine       Date:  1991-08       Impact factor: 3.641

7.  Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA.

Authors:  L F Erdile; M A Brandt; D J Warakomski; G J Westrack; A Sadziene; A G Barbour; J P Mays
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

Review 8.  Industrial production of heterologous proteins by fed-batch cultures of the yeast Saccharomyces cerevisiae.

Authors:  O Mendoza-Vega; J Sabatié; S W Brown
Journal:  FEMS Microbiol Rev       Date:  1994-12       Impact factor: 16.408

9.  High level of expression of a protective antigen of schistosomes in Saccharomyces cerevisiae.

Authors:  G Loison; A Vidal; A Findeli; C Roitsch; J M Balloul; Y Lemoine
Journal:  Yeast       Date:  1989 Nov-Dec       Impact factor: 3.239

10.  Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi.

Authors:  S Bergström; V G Bundoc; A G Barbour
Journal:  Mol Microbiol       Date:  1989-04       Impact factor: 3.501

View more
  1 in total

1.  Characterization of an anti-Borrelia burgdorferi OspA conformational epitope by limited proteolysis of monoclonal antibody-bound antigen and mass spectrometric peptide mapping.

Authors:  V Legros; C Jolivet-Reynaud; N Battail-Poirot; C Saint-Pierre; E Forest
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.